🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Glenmark Pharmaceuticals s.r.o. — Licensed Medicines

11 medicines held by Glenmark Pharmaceuticals s.r.o. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 11 products held by Glenmark Pharmaceuticals s.r.o.
MedicineActive substanceLicence holderStatus
Olazax 10 mg tablets
EU/1/09/597/003
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 15 mg tablets
EU/1/09/597/004
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 20 mg tablets
EU/1/09/597/005
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 5 mg tablets
EU/1/09/597/001
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 7.5 mg tablets
EU/1/09/597/002
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi
EU/1/09/592/002
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 10 mg orodispersible tablets
EU/1/09/592/003
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 15 mg orodispersible tablets
EU/1/09/592/004
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 20 mg orodispersible tablets
EU/1/09/592/005
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 5 mg orodispersible tablets
EU/1/09/592/001
Olanzapine Glenmark Pharmaceuticals s.r.o.
Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension
PA1543/002/001
Mometasone furoate, Olopatadine Glenmark Pharmaceuticals s.r.o. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.